HOMA-IR is a clinical formula that estimates insulin resistance from a fasting blood draw — no OGTT required. Published by Matthews et al. in 1985, it remains the most-cited surrogate for insulin sensitivity worldwide.

One-line summary

HOMA-IR = (fasting glucose × fasting insulin) / 405. Values < 2.0 normal, 2.0–2.5 borderline, > 2.5 insulin resistance, > 5.0 severe. Always interpret with a clinician.

Formula

HOMA-IR = (Fasting Glucose mg/dL × Fasting Insulin μU/mL) / 405

For SI units: HOMA-IR = (Glucose mmol/L × Insulin μU/mL) / 22.5

If you already have fasting glucose and fasting insulin results, you can use the HOMA-IR calculator to run the same formula and discuss the result with your clinician.

Reference ranges

HOMA-IRClassClinical meaning
< 2.0NormalInsulin sensitive
2.0–2.5BorderlineLifestyle intervention recommended
2.5–5.0Insulin resistanceClinical evaluation
> 5.0SevereEndocrinology consult

Why it matters

  • Predicts type 2 diabetes 5–10 years before fasting glucose rises
  • Detects PCOS, NAFLD, metabolic syndrome
  • Tracks treatment response
  • Easier than OGTT or clamp

How to test

  1. 12-hour overnight fast
  2. Single morning blood draw
  3. Lab measures glucose + insulin
  4. Calculate HOMA-IR

Limitations

  • Not valid in type 1 diabetes (no endogenous insulin)
  • Insulin assays vary between labs
  • Not validated in pregnancy
  • Less reliable in advanced type 2 (beta-cell failure)

Frequently asked questions

What is a normal HOMA-IR?

In adults, HOMA-IR < 2.0 is generally considered normal. Values 2.0–2.5 are borderline and > 2.5 indicate insulin resistance.

Can I lower my HOMA-IR?

Yes. Weight loss, regular exercise (especially resistance training), low-glycemic diet, adequate sleep and stress management can reduce HOMA-IR by 30–50% within 12 weeks.

Is HOMA-IR a diagnosis?

No — it's a screening surrogate. Clinical diagnosis requires fasting glucose, HbA1c, OGTT and physician evaluation.

How often should I test?

Annually for at-risk adults (BMI > 25, family history). Every 3–6 months when actively treating insulin resistance.


Medical disclaimer: This content is for educational purposes only and does not replace individual medical advice.